Xencor | Beban Penjualan Dan Administrasi



Selling And Administration Expenses Perubahan Tanggal
AbbVie USD 3.25B 40M 2025-06
Alnylam Pharmaceuticals USD 323.31M 83.36M 2025-06
Amgen USD 1.69B 4M 2025-06
Arrowhead Research USD 30.95M 3.06M 2025-06
AstraZeneca USD 5.01B 1.42B 2025-06
Biogen USD 583.8M 11.3M 2025-06
Bristol-Myers Squibb USD 1.71B 129M 2025-06
Cytokinetics USD 65.72M 8.35M 2025-06
GlaxoSmithKline GBP 2.14B 80M 2025-06
J&J USD 5.89B 777M 2025-06
MacroGenics USD 9.3M 18.51M 2025-06
Merck USD 2.63B 104M 2025-06
Novartis USD 3.44B 384M 2025-06
Pfizer USD 3.42B 406M 2025-06
Regeneron Pharmaceuticals USD 634.2M 1.2M 2025-06
Roche Holding CHF 3.61B 381M 2024-12
Xencor USD 15.11M 2.22M 2025-06


Xencor Beban Penjualan Dan Administrasi - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Sep 2025.